Gynae BT_Lucknow_2018

What do we know about dose to pathological nodes?

Nodal recurrence in pathological nodes after boost

Ramlov et al, Acta Oncol, 2015: limited dose effect for pathological nodes (~55- 65Gy boosts)

Pittsburgh, IJROBP 2015:

0% after boost dose of 55Gy

EMBRACE I:

12% failures within nodes boosted to a median dose of 59Gy

6